Picture of AC Immune SA logo

ACIU AC Immune SA News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

AC Immune SA expected to post a loss of 23 rappen a share - Earnings Preview

* AC Immune SA  ACIU.OQ   ACIU.O  is expected to show no
change in
quarterly revenue when it reports  results on April 26
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for AC Immune SA is for
a
loss of 23 rappen per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for AC Immune
SA is
$9​, above​ its last closing price of $2.18. ​​​

This summary was machine generated April 24 at 15:27 GMT.  All
figures in Swiss francs  unless otherwise stated

Recent news on AC Immune SA

See all news